Search results for "Opioids"


 
Results 1 - 10 of about 311 for "Opioids".
Sort by: Relevance | Newest | Oldest

Intervention for opioids appeared to reduce use, with no impact on pain

A trial in the U.K. randomly assigned patients with chronic noncancer pain to receive a group-based educational intervention or usual care and measured effects on opioid use and perceived pain at 12 months.
https://acpinternist.org/weekly/archives/2023/05/30/2.htm
30 May 2023

RSV vaccine approved; several actions on opioids

This column reviews recent recalls, alerts, and approvals.
https://acpinternist.org/archives/2023/06/rsv-vaccine-approved-several-actions-on-opioids.htm
1 Jun 2023

Overdose risk may be highest in week after hospital discharge for patients on long-term opioids

During the first seven days after hospital discharge, patients prescribed long-term opioid therapy overdosed on opioids at a rate six times higher than in other time periods, a retrospective study in one health system found.
https://acpinternist.org/weekly/archives/2023/01/31/4.htm
31 Jan 2023

Q&A: DEA requires addiction training for all prescribers

The Drug Enforcement Administration is requiring eight hours of training related to substance use disorder treatment, sending clinicians scurrying to their continuing education providers for help.
https://acpinternist.org/archives/2023/05/dea-requires-addiction-training-for-all-prescribers.htm
1 May 2023

ACP resources can help fulfill new DEA training requirement on substance use disorders

Starting June 27, 2023, the Drug Enforcement Administration (DEA) will require registered physicians to provide a one-time attestation that they have completed eight hours of training, and ACP's education resources can help.
https://acpinternist.org/weekly/archives/2023/04/11/5.htm
11 Apr 2023

Big barrier to buprenorphine removed

The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
https://acpinternist.org/archives/2023/03/big-barrier-to-buprenorphine-removed.htm
1 Mar 2023

Pandemic may have led to changes in buprenorphine treatment initiation, retention

While more U.S. patients received buprenorphine for opioid use disorder between March 13 and Dec. 1, 2020, than during the same period in 2019, there were about 17% fewer new prescriptions than expected, a recent study found.
https://acpinternist.org/weekly/archives/2022/12/13/2.htm
13 Dec 2022

Learn the latest on excessive alcohol use, opioid use disorder

This month's issue addresses alcohol use and misuse, prescribing buprenorphine, and improving health care's response to future pandemics.
https://acpinternist.org/archives/2023/03/learn-the-latest-on-excessive-alcohol-use-opioid-use-disorder.htm
1 Mar 2023

CDC updates guideline on prescribing opioids for pain management

The guideline covers recommendations for primary care and other clinicians managing pain in outpatient settings and after patients are discharged from hospitals, EDs, or other facilities.
https://acpinternist.org/weekly/archives/2022/11/08/1.htm
8 Nov 2022

Register now for ACP's one-day course on pain management in an environment of opioid de-escalation

The virtual course on Tuesday, Oct. 5, will provide education for internists on the latest strategies and best practices in pain management.
https://acpinternist.org/weekly/archives/2021/09/21/5.htm
21 Sep 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next